Posted May. 1, 2012 at 9:41 a.m.

Premium Lock Pozen losses increase but arthritis drug royalties grow

Published: 2012-05-01 09:41:30
Updated: 2012-05-01 09:41:30


The Chapel Hill-based drug firm reports a loss of $8.4 million for the first quarter, up from $5.7 million a year ago. However, sales of the arthirtis drug Vimovo are growing....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders